• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗逆转录病毒治疗(HAART)后 HIV 阳性病例的血脂指标变化。

Changes in Lipid Indices in HIV+ Cases on HAART.

机构信息

State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China.

Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou 310003, China.

出版信息

Biomed Res Int. 2019 Feb 5;2019:2870647. doi: 10.1155/2019/2870647. eCollection 2019.

DOI:10.1155/2019/2870647
PMID:30868068
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6379880/
Abstract

We assess long-term changes in lipid levels in human immunodeficiency disease- (HIV-) infected patients undergoing highly active antiretroviral treatment (HAART) and their association with diabetes mellitus (DM) and thyroid dysfunction. We observed changes in the levels of total cholesterol (TC) and total triglyceride (TG) of 63 HIV-infected patients in the 6 years from starting HAART and analyzed correlations between relevant parameters. TC levels of patients with normal baseline TC levels as well as those diagnosed with DM or impaired fasting glucose (IFG) increased significantly (  < 0.05) as did the TG levels of patients with normal baseline TG levels (  < 0.05). TC levels of patients with hypercholesterolemia in the year HAART was initiated were significantly higher than those of patients with normal baseline TC levels (  < 0.05) for all 6 years. TC levels of patients diagnosed with DM were significantly higher than those with euglycemia (  < 0.05) 2 and 4 years after HAART commencement. Levels of TC, high-density lipoprotein-cholesterol (HDL-C), and low-density lipoprotein-cholesterol (LDL-C) were correlated negatively with viral load, whereas levels of TC and very-low-density lipoprotein-cholesterol (VLDL-C) were correlated positively with CD4+ cell counts before HAART commencement. Linear mixed-effect model demonstrated disturbance of glucose metabolism and HAART containing nevirapine and CD4+ cell count were positively correlated with TC levels after HAART commencement. These findings suggest that there are changes in the lipid levels of patients undergoing HAART, with the potential risk of dyslipidemia.

摘要

我们评估了接受高效抗逆转录病毒治疗(HAART)的人类免疫缺陷病毒(HIV)感染患者的血脂水平的长期变化及其与糖尿病(DM)和甲状腺功能障碍的关系。我们观察了 63 名 HIV 感染患者在开始 HAART 的 6 年内总胆固醇(TC)和总甘油三酯(TG)水平的变化,并分析了相关参数之间的相关性。基线 TC 水平正常以及患有 DM 或空腹血糖受损(IFG)的患者的 TC 水平显著升高(  < 0.05),基线 TG 水平正常的患者的 TG 水平也显著升高(  < 0.05)。起始 HAART 年度高胆固醇血症患者的 TC 水平显著高于基线 TC 水平正常的患者(  < 0.05),所有 6 年均如此。起始 HAART 后 2 年和 4 年,DM 患者的 TC 水平明显高于血糖正常的患者(  < 0.05)。TC、高密度脂蛋白胆固醇(HDL-C)和低密度脂蛋白胆固醇(LDL-C)水平与病毒载量呈负相关,而 TC 和极低密度脂蛋白胆固醇(VLDL-C)水平与 HAART 前的 CD4+细胞计数呈正相关。线性混合效应模型表明,葡萄糖代谢紊乱和包含奈韦拉平的 HAART 与 CD4+细胞计数与 HAART 后 TC 水平呈正相关。这些发现表明,接受 HAART 的患者的血脂水平发生了变化,存在血脂异常的潜在风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144e/6379880/691bb16d2970/BMRI2019-2870647.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144e/6379880/dd2850b36271/BMRI2019-2870647.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144e/6379880/691bb16d2970/BMRI2019-2870647.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144e/6379880/dd2850b36271/BMRI2019-2870647.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144e/6379880/691bb16d2970/BMRI2019-2870647.002.jpg

相似文献

1
Changes in Lipid Indices in HIV+ Cases on HAART.抗逆转录病毒治疗(HAART)后 HIV 阳性病例的血脂指标变化。
Biomed Res Int. 2019 Feb 5;2019:2870647. doi: 10.1155/2019/2870647. eCollection 2019.
2
Changes in lipid profile over 24 months among adults on first-line highly active antiretroviral therapy in the home-based AIDS care program in rural Uganda.乌干达农村家庭艾滋病护理项目中接受一线高效抗逆转录病毒治疗的成年人在24个月内的血脂变化情况。
J Acquir Immune Defic Syndr. 2008 Mar 1;47(3):304-11. doi: 10.1097/qai.0b013e31815e7453.
3
Severe dyslipidemia and immune activation in HIV patients with dysglycemia.血糖异常的HIV患者中的严重血脂异常和免疫激活
HIV Clin Trials. 2016 Sep;17(5):189-96. doi: 10.1080/15284336.2016.1207297. Epub 2016 Jul 13.
4
Antiretroviral treatment associated hyperglycemia and dyslipidemia among HIV infected patients at Burayu Health Center, Addis Ababa, Ethiopia: a cross-sectional comparative study.埃塞俄比亚亚的斯亚贝巴布拉尤健康中心HIV感染患者中抗逆转录病毒治疗相关的高血糖和血脂异常:一项横断面比较研究
BMC Res Notes. 2014 Jun 21;7:380. doi: 10.1186/1756-0500-7-380.
5
Impact of HIV infection and HAART on serum lipids in men.HIV感染及高效抗逆转录病毒治疗对男性血清脂质的影响。
JAMA. 2003 Jun 11;289(22):2978-82. doi: 10.1001/jama.289.22.2978.
6
Serum lipid levels associated with increased risk for cardiovascular disease is associated with highly active antiretroviral therapy (HAART) in HIV-1 infection.在HIV-1感染中,与心血管疾病风险增加相关的血清脂质水平与高效抗逆转录病毒疗法(HAART)有关。
Int J STD AIDS. 2000 Jul;11(7):451-5. doi: 10.1258/0956462001916236.
7
Prevalence of dyslipidemia among human immunodeficiency virus infected Nigerians.尼日利亚人类免疫缺陷病毒感染者中血脂异常的患病率。
Ann Afr Med. 2013 Jan-Mar;12(1):24-8. doi: 10.4103/1596-3519.108246.
8
Prevalence of dyslipidaemia among HIV-infected patients receiving combination antiretroviral therapy in North Shewa, Ethiopia.埃塞俄比亚北谢瓦接受联合抗逆转录病毒治疗的艾滋病毒感染患者血脂异常的患病率。
PLoS One. 2021 Apr 27;16(4):e0250328. doi: 10.1371/journal.pone.0250328. eCollection 2021.
9
Longitudinal changes in serum lipids among HIV-infected men on highly active antiretroviral therapy.接受高效抗逆转录病毒治疗的HIV感染男性血清脂质的纵向变化。
HIV Med. 2007 Jul;8(5):280-7. doi: 10.1111/j.1468-1293.2007.00470.x.
10
Dyslipidemia in ART-Naive HIV-Infected Persons in Nigeria--Implications for Care.尼日利亚初治HIV感染者的血脂异常——对治疗的启示
J Int Assoc Provid AIDS Care. 2015 Jul-Aug;14(4):355-9. doi: 10.1177/2325957414555227. Epub 2014 Oct 20.

引用本文的文献

1
Clinical Applications and Therapeutic Mechanisms of Chinese Herbal Medicine Yiaikang Capsules in Treating Acquired Immune Deficiency Syndrome.中药益艾康胶囊治疗获得性免疫缺陷综合征的临床应用及治疗机制
Infect Drug Resist. 2025 Jul 5;18:3317-3327. doi: 10.2147/IDR.S526449. eCollection 2025.
2
Metabolic, Mitochondrial, and Inflammatory Effects of Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate in Asymptomatic Antiretroviral-Naïve People with HIV.无症状抗逆转录病毒初治 HIV 感染者中依非韦伦、恩曲他滨和富马酸替诺福韦二吡呋酯的代谢、线粒体和炎症效应。
Int J Mol Sci. 2024 Aug 1;25(15):8418. doi: 10.3390/ijms25158418.
3

本文引用的文献

1
Associations of gender and serum total cholesterol with CD4+ T cell count and HIV RNA load in antiretroviral-naïve individuals in Addis Ababa.在未接受抗逆转录病毒治疗的亚的斯亚贝巴个体中,性别和血清总胆固醇与 CD4+T 细胞计数和 HIV RNA 载量的关联。
BMC Public Health. 2018 Jul 31;18(1):943. doi: 10.1186/s12889-018-5852-4.
2
Dietary Patterns and Physical Activity Correlate With Total Cholesterol Independently of Lipid-Lowering Drugs and Antiretroviral Therapy in Aging People Living With Human Immunodeficiency Virus.在感染人类免疫缺陷病毒的老年人中,饮食模式和身体活动与总胆固醇相关,且独立于降脂药物和抗逆转录病毒疗法。
Open Forum Infect Dis. 2018 Mar 23;5(4):ofy067. doi: 10.1093/ofid/ofy067. eCollection 2018 Apr.
3
Interaction between antiretroviral therapy regimens and body mass index on triglyceride levels in people living with HIV: a cross-sectional and longitudinal study.
抗逆转录病毒疗法方案与身体质量指数对 HIV 感染者甘油三酯水平的相互影响:一项横断面和纵向研究。
Lipids Health Dis. 2024 Jul 30;23(1):232. doi: 10.1186/s12944-024-02224-8.
4
Network-based multi-omics integration reveals metabolic at-risk profile within treated HIV-infection.基于网络的多组学整合揭示了治疗后 HIV 感染中的代谢风险特征。
Elife. 2023 Feb 16;12:e82785. doi: 10.7554/eLife.82785.
5
Prevalence and predictors of dyslipidemia among HAART treated and HAART naive HIV positive clients attending Debre Tabor Hospital, Debre Tabor, Ethiopia.埃塞俄比亚德布雷塔博尔市德布雷塔博尔医院接受高效抗逆转录病毒治疗(HAART)和未接受过HAART治疗的HIV阳性患者血脂异常的患病率及预测因素
Heliyon. 2022 Oct 29;8(11):e11342. doi: 10.1016/j.heliyon.2022.e11342. eCollection 2022 Nov.
6
Long-term intra- and inter-individual biological variation of serum lipid of HIV-infected and uninfected men participating in the Los Angeles Multi-Center AIDS Cohort Study (MACS).感染和未感染 HIV 的男性参与洛杉矶多中心艾滋病队列研究(MACS)的血清脂质的个体内和个体间长期生物学变异。
Lipids Health Dis. 2022 Jul 27;21(1):63. doi: 10.1186/s12944-022-01668-0.
7
Expression of the inflammasome components and its relationship with cardiovascular risk markers in people living with HIV-1.HIV-1 感染者中炎症小体成分的表达及其与心血管风险标志物的关系。
Biomedica. 2022 Jun 1;42(2):239-241. doi: 10.7705/biomedica.6320.
8
Comparison of Tolerability and Impact on Metabolic Profiles of Antiretroviral Regimens Containing Darunavir/Ritonavir or Darunavir/Cobicistat in Romanian HIV Infected Patients.在罗马尼亚艾滋病毒感染患者中比较含达芦那韦/利托那韦或达芦那韦/考比司他的抗逆转录病毒方案的耐受性及对代谢谱的影响
Biomedicines. 2021 Aug 9;9(8):987. doi: 10.3390/biomedicines9080987.
9
Pathological significance of abnormal recepteur d'origine nantais and programmed death ligand 1 expression in colorectal cancer.异常的南特起源受体和程序性死亡配体1表达在结直肠癌中的病理意义。
World J Gastrointest Oncol. 2020 Nov 15;12(11):1216-1236. doi: 10.4251/wjgo.v12.i11.1216.
Thyroid stimulating hormone exhibits the impact on LDLR/LDL-c via up-regulating hepatic PCSK9 expression.
促甲状腺激素通过上调肝脏前蛋白转化酶枯草溶菌素9(PCSK9)的表达,对低密度脂蛋白受体(LDLR)/低密度脂蛋白胆固醇(LDL-c)产生影响。
Metabolism. 2017 Nov;76:32-41. doi: 10.1016/j.metabol.2017.07.006. Epub 2017 Aug 2.
4
Metabolic Complications among Korean Patients with HIV Infection: The Korea HIV/AIDS Cohort Study.韩国HIV感染患者的代谢并发症:韩国HIV/AIDS队列研究
J Korean Med Sci. 2017 Aug;32(8):1268-1274. doi: 10.3346/jkms.2017.32.8.1268.
5
Severe dyslipidemia and immune activation in HIV patients with dysglycemia.血糖异常的HIV患者中的严重血脂异常和免疫激活
HIV Clin Trials. 2016 Sep;17(5):189-96. doi: 10.1080/15284336.2016.1207297. Epub 2016 Jul 13.
6
Prevalence and Influencing Factors of Thyroid Dysfunction in HIV-Infected Patients.HIV感染患者甲状腺功能障碍的患病率及影响因素
Biomed Res Int. 2016;2016:3874257. doi: 10.1155/2016/3874257. Epub 2016 Apr 20.
7
Monocytes from HIV-infected individuals show impaired cholesterol efflux and increased foam cell formation after transendothelial migration.来自HIV感染者的单核细胞在跨内皮迁移后表现出胆固醇流出受损和泡沫细胞形成增加。
AIDS. 2015 Jul 31;29(12):1445-57. doi: 10.1097/QAD.0000000000000739.
8
Managing dyslipidemia in HIV/AIDS patients: challenges and solutions.管理艾滋病毒/艾滋病患者的血脂异常:挑战与解决方案。
HIV AIDS (Auckl). 2014 Dec 17;7:1-10. doi: 10.2147/HIV.S46028. eCollection 2015.
9
Multicenter cohort study of diabetes mellitus and impaired fasting glucose in HIV-infected patients in China.中国HIV感染患者糖尿病和空腹血糖受损的多中心队列研究。
J Acquir Immune Defic Syndr. 2015 Mar 1;68(3):298-303. doi: 10.1097/QAI.0000000000000474.
10
Dyslipidemia and cardiovascular risk in human immunodeficiency virus infection.人类免疫缺陷病毒感染中的血脂异常与心血管风险
Endocrinol Metab Clin North Am. 2014 Sep;43(3):665-84. doi: 10.1016/j.ecl.2014.06.003.